|
ICMR slams BHU's Covaxin study, says it wasn't part of it
![IndiaTimes]()
Monday, 20 May 2024
Indian Council of Medical Research criticizes a recently-published study on Covaxin's safety analysis for poor methodology. The study wrongly acknowledges ICMR. Director Rajiv Bahl clarifies the lack of comparison group for side effects attribution. Nearly one-third of Covaxin recipients reported adverse events. ICMR warns of legal action for unapproved acknowledgements.
|
|
|
|
💡 newsR Knowledge: Other News Mentions
You Might Like
|
|
|
Monday, 20 May 2024
